Cellular uptake of 99mTcN-NOET in human leukaemic HL-60 cells is related to calcium channel activation and cell proliferation

  • Stephanie Guillermet
  • Jean-Philippe Vuillez
  • Eric Fontaine
  • Jean-Pierre Caravel
  • Danièle Marti-Batlle
  • Roberto Pasqualini
  • Daniel FagretEmail author
Original Article



A major goal of nuclear oncology is the development of new radiolabelled tracers as proliferation markers. Intracellular calcium waves play a fundamental role in the course of the cell cycle. These waves occur in non-excitable tumour cells via store-operated calcium channels (SOCCs). Bis(N-ethoxy, N-ethyldithiocarbamato) nitrido technetium (V)-99m (99mTcN-NOET) has been shown to interact with L-type voltage-operated calcium channels (VOCCs) in cultured cardiomyocytes. Considering the analogy between VOCCs and SOCCs, we sought to determine whether 99mTcN-NOET also binds to activated SOCCs in tumour cells in order to clarify the potential value of this tracer as a proliferation marker.


Uptake kinetics of 99mTcN-NOET were measured in human leukaemic HL-60 cells over 60 min and the effect of several calcium channel modulators on 1-min tracer uptake was studied. The uptake kinetics of 99mTcN-NOET were compared both with the variations of cytosolic free calcium concentration measured by indo-1/AM and with the variations in the SG2M cellular proliferation index.


All calcium channel inhibitors significantly decreased the cellular uptake of 99mTcN-NOET whereas the activator thapsigargin induced a significant 10% increase. In parallel, SOCC activation by thapsigargin, as measured using the indo-1/AM probe, was inhibited by nicardipine. These results indicate that the uptake of 99mTcN-NOET is related to the activation of SOCCs. Finally, a correlation was observed between the tracer uptake and variations in the proliferation index SG2M.


The uptake of 99mTcN-NOET seems to be related to SOCC activation and to cell proliferation in HL-60 cells. These results indicate that 99mTcN-NOET might be a marker of cell proliferation.


Nuclear imaging Radiopharmaceuticals Tumour imaging 99mTcN-NOET Proliferation marker 



The authors wish to thank Prof. M. Villaz, Dr. J. Boutonnat and Dr. L. Riou for their helpful comments and suggestions and P. Champelovier for his expert technical assistance.

Financial support for this work was provided by the Institut National pour la Recherche Scientifique et Médicale (INSERM), by Cis Bio International-Schering SA and by the Association pour la Recherche contre le Cancer (ARC). All experiments were reviewed, approved and performed under the authority of individuals allowed to work on living animals by the French government (D. Fagret, authorisation 38-01).


  1. 1.
    Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 1998;4:1334–6CrossRefPubMedGoogle Scholar
  2. 2.
    Vesselle H, Grierson J, Muzi M, Pugsley JM, Schmidt RA, Rabinowitz P, et al. In vivo validation of 3′ deoxy-3′-[18F]fluorothymidine ([18F]FLT) as a proliferation imaging tracer in humans: correlation of [18F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumours. Clin Cancer Res 2002;8:3315–23PubMedGoogle Scholar
  3. 3.
    Rasey JS, Grierson JR, Wiens LW, Kolb PD, Schwartz JL. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med 2002;43:1210–7PubMedGoogle Scholar
  4. 4.
    Minn H, Joensuu H, Ahonen A, Kleni P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer 1988;61:1776–81PubMedGoogle Scholar
  5. 5.
    Haberkorn U, Strauss LG, Reisser C, Haag D, Dimitrakopoulou A, Ziegler S, et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med 1991;32:1548–55PubMedGoogle Scholar
  6. 6.
    Higashi K, Clavo AC, Wahl RL. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 1993;34:414–9PubMedGoogle Scholar
  7. 7.
    Minn H, Clavo AC, Grenman R, Wahl RL. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 1995;36:252–8PubMedGoogle Scholar
  8. 8.
    Smith TA. FDG uptake, tumour characteristics and response to therapy : a review. Nucl Med Commun 1998;19:97–105PubMedGoogle Scholar
  9. 9.
    Denoyer D, Perek N, Le Jeune N, Cornillon J, Dubois F. Correlation between 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines. Eur J Nucl Med Mol Imaging 2005;32. DOI 10.1007/s00259-005-1773-4Google Scholar
  10. 10.
    Papantoniou VJ, Souvatzoglou MA, Valotassiou V, Louvrou AN, Ambela C, Koutsikos J, et al. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer. Breast Cancer Res 2004;6:R56–62Google Scholar
  11. 11.
    Whitaker M, Patel R. Calcium and cell cycle control. Development 1990;108:525–42PubMedGoogle Scholar
  12. 12.
    Means AR. Calcium, calmodulin and cell cycle regulation. FEBS Lett 1994;347:1–4CrossRefPubMedGoogle Scholar
  13. 13.
    Berridge MJ. Calcium signalling and cell proliferation. BioEssays 1995;17:491–500CrossRefPubMedGoogle Scholar
  14. 14.
    Putney JW Jr, McKay RR. Capacitative calcium entry channels. BioEssays 1999;21:38–46CrossRefPubMedGoogle Scholar
  15. 15.
    Barritt GJ. Receptor-activated Ca2+ inflow in animal cells: variety of pathways tailored to meet different intracellular Ca2+ signalling requirements. Biochem J 1999;337:153–69CrossRefPubMedGoogle Scholar
  16. 16.
    Aussel C, Marhaba R, Pelassy C, Breittmayer JP. Submicromolar La3+ concentrations block the calcium release-activated channel, and impair CD69 and CD25 expression in CD3− or thapsigargin-activated Jurkat cells. Biochem J 1996;313:909–13PubMedGoogle Scholar
  17. 17.
    Leung YM, Kwan CY, Loh TT. Capacitative Ca2+ entry in HL-60 cells: tetrandrine and SK & F 96365 as probes. Zhongguo Yao Li Xue Bao 1996;17:97–101PubMedGoogle Scholar
  18. 18.
    Harper JL, Camerini-Otero CS, Li AH, Kim SA, Jacobson KA, Daly JW. Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells. Biochem Pharmacol 2003;65:329–38Google Scholar
  19. 19.
    Pasqualini R, Duatti A, Bellande E, Comazzi V, Brucato V, Hoffschir D, et al. Bis(dithiocarbamato) nitrido technetium-99m radiopharmaceuticals: a class of neutral myocardial imaging agents. J Nucl Med 1994;35:334–41PubMedGoogle Scholar
  20. 20.
    Ghezzi C, Fagret D, Arvieux CC, Mathieu JP, Bontron R, Pasqualini R, et al. Myocardial kinetics of TcN-NOET: a neutral lipophilic complex tracer of regional myocardial blood flow. J Nucl Med 1995;36:1069–77PubMedGoogle Scholar
  21. 21.
    Fagret D, Marie PY, Brunotte F, Giganti M, Le Guludec D, Bertrand A, et al. Myocardial perfusion imaging with technetium 99m-Tc NOET: comparison with thallium-201 and coronary angiography. J Nucl Med 1995;36:936–43PubMedGoogle Scholar
  22. 22.
    Riou L, Ghezzi C, Mouton O, Mathieu JP, Pasqualini R, Comet M, et al. Cellular uptake mechanisms of 99mTcN-NOET in cardiomyocytes from newborn rats. Circulation 1998;98:2591–7PubMedGoogle Scholar
  23. 23.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–75PubMedGoogle Scholar
  24. 24.
    Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440–50PubMedGoogle Scholar
  25. 25.
    Putney JW Jr. The pharmacology of capacitative calcium entry. Mol Interv 2001;1:84–94PubMedGoogle Scholar
  26. 26.
    Vazquez G, de Boland AR, Boland RL. 1alpha,25-dihydroxy-vitamin-D3-induced store operated Ca2+ influx in skeletal muscle cells. Modulation by phospholipase c, protein kinase c, and tyrosine kinases. J Biol Chem 1998;273:33954–60CrossRefPubMedGoogle Scholar
  27. 27.
    Auld A, Chen J, Brereton HM, Wang YJ, Gregory RB, Barritt GJ. Store-operated Ca2+ inflow in Reuber hepatoma cells is inhibited by voltage-operated Ca2+ channel antagonists and, in contrast to freshly isolated hepatocytes, does not require a pertussis toxin-sensitive trimeric GTP-binding protein. Biochim Biophys Acta 2000;1497:11–26CrossRefPubMedGoogle Scholar
  28. 28.
    Willmott NJ, Choudhury Q, Flower RJ. Functional importance of the dihydropyridine sensitive, yet voltage-insensitive store-operated Ca2+ influx of U937 cells. FEBS Lett 1996;394:159–64CrossRefPubMedGoogle Scholar
  29. 29.
    Leung YM, Kwan CY, Loh TT. Dual effects of SK&F 96365 in human leukemic HL-60 cells. Inhibition of calcium entry and activation of a novel cation influx pathway. Biochem Pharmacol 1996;51:605–12Google Scholar
  30. 30.
    Thastrup O, Cullen PJ, Drobak BK, Hanley MR, Dawson AP. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci U S A 1990;87:2466–70PubMedGoogle Scholar
  31. 31.
    Mason MJ, Garcia-Rodriguez C, Grinstein S. Coupling between intracellular Ca2+ stores and the Ca2+ permeability of the plasma membrane. Comparison of the effects of thapsigargin, 2,5-di-(tert-butyl)-1,4-hydroquinone, and cyclopiazonic acid in rat thymic lymphocytes. J Biol Chem 1991;266:20856–62PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Stephanie Guillermet
    • 1
  • Jean-Philippe Vuillez
    • 1
  • Eric Fontaine
    • 2
  • Jean-Pierre Caravel
    • 1
  • Danièle Marti-Batlle
    • 1
  • Roberto Pasqualini
    • 3
  • Daniel Fagret
    • 1
    Email author
  1. 1.INSERM 0340 Radiopharmaceutiques BiocliniquesUniversité de GrenobleLa TroncheFrance
  2. 2.INSERM E 221 Laboratoire de Bioénergétique Fondamentale et AppliquéeUniversité de GrenobleGrenobleFrance
  3. 3.Cis Bio International Schering SAGif-sur-YvetteFrance

Personalised recommendations